﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Silicon Investor - Steroidogenesis Inhibitors (STGI)</title><copyright>Copyright © 2026 Knight Sac Media.  All rights reserved.</copyright><link>https://www.siliconinvestor.com/subject.aspx?subjectid=18573</link><description>
STGI has just recently begun trading.  The company is run by Dr. Alfred Sapse, a world renown researcher.  The company has developed a drug called ANTI-CORT which is a drug used in the AIDS drug "cocktail." Anti-Cort is currently going through the double blind study for FDA approval here, but already is available in international markets.  Has anyone heard anything else on this company?  I think they might be bought out by a larger pharmaceutical company down the road.  Bert</description><image><url>https://www.siliconinvestor.com/images/Logo380x132.png</url><title>SI - Steroidogenesis Inhibitors (STGI)</title><link>https://www.siliconinvestor.com/subject.aspx?subjectid=18573</link><width>380</width><height>132</height></image><ttl>10</ttl></channel></rss>